ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 170 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $63 | -26.7% | 122,000 | -10.2% | 0.00% | – |
Q1 2023 | $86 | +50.9% | 135,834 | +53.4% | 0.00% | – |
Q4 2022 | $57 | -100.0% | 88,534 | 0.0% | 0.00% | – |
Q3 2022 | $153,000 | +24.4% | 88,534 | -10.9% | 0.00% | – |
Q2 2022 | $123,000 | +43.0% | 99,400 | -24.6% | 0.00% | – |
Q1 2022 | $86,000 | -30.6% | 131,836 | +15.7% | 0.00% | – |
Q4 2021 | $124,000 | -70.4% | 113,936 | -50.6% | 0.00% | – |
Q3 2021 | $419,000 | +54.0% | 230,436 | +123.9% | 0.00% | – |
Q2 2021 | $272,000 | -20.2% | 102,936 | +8.8% | 0.00% | – |
Q1 2021 | $341,000 | +25.4% | 94,605 | -12.4% | 0.00% | – |
Q4 2020 | $272,000 | -0.7% | 107,954 | -0.7% | 0.00% | – |
Q3 2020 | $274,000 | -23.2% | 108,754 | 0.0% | 0.00% | – |
Q2 2020 | $357,000 | +36.8% | 108,754 | +2.1% | 0.00% | – |
Q1 2020 | $261,000 | -46.1% | 106,497 | +3.9% | 0.00% | – |
Q4 2019 | $484,000 | +21.0% | 102,524 | +9.7% | 0.00% | – |
Q3 2019 | $400,000 | -25.9% | 93,463 | +0.8% | 0.00% | – |
Q2 2019 | $540,000 | +52.5% | 92,680 | +0.9% | 0.00% | – |
Q1 2019 | $354,000 | +107.0% | 91,877 | +0.4% | 0.00% | – |
Q4 2018 | $171,000 | -49.9% | 91,477 | -14.2% | 0.00% | – |
Q3 2018 | $341,000 | +45.7% | 106,556 | +37.7% | 0.00% | – |
Q2 2018 | $234,000 | -22.0% | 77,368 | +1.1% | 0.00% | – |
Q1 2018 | $300,000 | +30.4% | 76,525 | +37.7% | 0.00% | – |
Q4 2017 | $230,000 | -44.2% | 55,569 | -17.3% | 0.00% | – |
Q3 2017 | $412,000 | +28.3% | 67,169 | +30.0% | 0.00% | – |
Q2 2017 | $321,000 | -22.5% | 51,669 | -20.8% | 0.00% | – |
Q1 2017 | $414,000 | +18.6% | 65,235 | 0.0% | 0.00% | – |
Q4 2016 | $349,000 | -4.9% | 65,235 | +0.1% | 0.00% | – |
Q3 2016 | $367,000 | +2.5% | 65,200 | 0.0% | 0.00% | – |
Q2 2016 | $358,000 | -7.7% | 65,200 | +24.7% | 0.00% | – |
Q1 2016 | $388,000 | -10.8% | 52,300 | 0.0% | 0.00% | – |
Q4 2015 | $435,000 | -47.8% | 52,300 | -43.5% | 0.00% | – |
Q3 2015 | $833,000 | -15.2% | 92,500 | +13.1% | 0.00% | – |
Q2 2015 | $982,000 | +81.5% | 81,800 | +62.9% | 0.00% | – |
Q1 2015 | $541,000 | +69.1% | 50,200 | -20.6% | 0.00% | – |
Q4 2014 | $320,000 | +91.6% | 63,200 | 0.0% | 0.00% | – |
Q3 2014 | $167,000 | -3.5% | 63,200 | +47.0% | 0.00% | – |
Q2 2014 | $173,000 | -12.2% | 43,000 | 0.0% | 0.00% | – |
Q1 2014 | $197,000 | -47.3% | 43,000 | -50.0% | 0.00% | – |
Q4 2013 | $374,000 | – | 86,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 12,546,493 | $22,835,000 | 1.71% |
MSD Partners, L.P. | 15,151,516 | $27,576,000 | 0.84% |
MSD Partners, L.P. | 7,575,758 | $13,788,000 | 0.42% |
CHIRON CAPITAL MANAGEMENT, LLC | 198,002 | $360,000 | 0.26% |
Avidity Partners Management LP | 3,000,000 | $5,460,000 | 0.12% |
Old West Investment Management, LLC | 211,513 | $384,000 | 0.10% |
MAGNOLIA CAPITAL ADVISORS LLC | 103,239 | $188,000 | 0.07% |
Virtus ETF Advisers LLC | 72,060 | $131,000 | 0.06% |
ACT WEALTH MANAGEMENT, LLC | 34,454 | $91,000 | 0.06% |
Allred Capital Management, LLC | 53,000 | $96,000 | 0.05% |